Factors Determining Tolerance to Nasal Allergen Exposure With Advanced Age in a Subset of Birch Pollen Allergic Subjects
NCT06459219 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 152
Last updated 2025-05-07
Summary
Nasal allergen study in patients aged 60+ with or without current respiratory allergy
Conditions
- Allergic Rhinitis
- Allergic Conjunctivitis
Sponsors & Collaborators
-
Sven Schneider, MD
lead OTHER
Eligibility
- Min Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-12-01
- Primary Completion
- 2027-10-01
- Completion
- 2028-10-01
Countries
- Austria
Study Locations
More Related Trials
-
Evaluation of Nasal Inflammatory Biomarkers
NCT03450031 ·Status: COMPLETED ·Phase: NA
-
Open Label Safety Study of a Birch Pollen Allergen Extract
NCT00818181 ·Status: COMPLETED ·Phase: PHASE2
-
Monocenter 6-period Study in Patients With Seasonal Allergic Rhinitis to Birch Pollen to Establish a Challenge Model With Natural Birch Pollen in an Environmental Challenge Chamber (ECC)
NCT01983865 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Recombinant Birch Pollen Allergen in the Treatment of Allergic Rhinoconjunctivitis
NCT00309062 ·Status: COMPLETED ·Phase: PHASE3
-
S.C. Immunotherapy With BM41 in Patients With Allergic Rhino-conjunctivitis Caused by Birch Pollen
NCT04912076 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Birch Pollen Immunotherapy in Local Allergic Rhinitis
NCT03157505 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Immunotherapy in the Nose
NCT01985542 ·Status: COMPLETED ·Phase: NA
-
Vienna Challenge Chamber Study Using RV658 in Subjects With Allergic Rhinitis
NCT01230619 ·Status: COMPLETED ·Phase: PHASE2
-
Innate Neutrophilic Nasal Inflammation in a Pollen Exposure Chamber
NCT03496103 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Intranasal Anti-IgE Antibodies on IgE Production
NCT03019237 ·Status: COMPLETED ·Phase: NA
-
A Study Of The Effects Of OC000459 In Subjects Known To Suffer From Grass Pollen Induced Allergic Rhinitis
NCT01448902 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of a Sublingual Immunotherapy Solution to Treat Patients Suffering From Birch Pollen Allergic Rhinoconjunctivitis
NCT01731249 ·Status: COMPLETED ·Phase: PHASE3
-
Immune Response of Individuals Vaccinated With Hypoallergenic Derivatives of the Major Birch Pollen Allergen, Bet v 1
NCT01353924 ·Status: UNKNOWN ·Phase: PHASE1
-
Pilot Trial to Elaborate a Cutaneous Antigen Neutralization Test in Patients Suffering From Rhinoconjunctivitis
NCT00461721 ·Status: COMPLETED
-
Intranasal SB-705498 in Allergic Rhinitis (AR) Patients
NCT01424397 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Tolerability of a Topical Microemulsion in Patients With Allergic Rhinitis Due to Sensitization to Pollen
NCT01478425 ·Status: COMPLETED ·Phase: PHASE4
-
Skin Prick Tests With AllerT in Subjects Allergic to Birch Pollen
NCT01719133 ·Status: COMPLETED ·Phase: PHASE1
-
Nasal Allergen Challenge Test as a Method to Detect Clinical Reactivity Against Birch Pollen
NCT06085963 ·Status: COMPLETED ·Phase: NA
-
SUBLIVAC FIX Birch Dose Tolerability/Dose Range Finding
NCT01639768 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Safety, and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic Rhinitis
NCT01484119 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Determine the Capacity of VAK694 When Combined With Allergen Immunotherapy to Bring About Specific Immune Tolerance
NCT01018693 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Tolerability of Two Different Administration Routes With SLITonePLUS Birch
NCT01191359 ·Status: COMPLETED ·Phase: PHASE2
-
Repeat Nasal Allergen Challenge
NCT00290368 ·Status: COMPLETED ·Phase: PHASE2
-
Validation of a Combined Symptom and Medication Score in Patients Suffering From Allergic Rhinoconjunctivitis
NCT04071249 ·Status: COMPLETED
-
OC000459 Dose Finding Study in Hay Fever Sufferers.
NCT00697281 ·Status: COMPLETED ·Phase: PHASE2